๐Ÿ‡ฒ๐Ÿ‡บ Country Profile

Mauritius

Indian pharmaceuticals serving Mauritius

๐Ÿ‡ฒ๐Ÿ‡บ $58.0M
All data from DGCIS India export records (fiscal year, Aprilโ€“March).
$58.0M
Scale
Mauritius' patients receive $58.0M in Indian pharmaceutical products annually โ€” almost entirely finished medicines ready for dispensing.
94%
Medicine
Overwhelmingly finished medicines โ€” drug formulations account for 94% of shipments.
1.6ร—
Trajectory
India's pharmaceutical supply to Mauritius has grown 1.6ร— over the past decade โ€” strong, sustained expansion.
Context
Part of India's pharmaceutical supply network across Africa.
โœฆ
Impact
Indian pharmaceutical companies have both exported to and invested directly in Mauritius โ€” building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharmaceutical categories from DGCIS

Category Mix — FY 2025–26 DGCIS
Medicines $54.6M (93.6%) Surgical & Hospital Supplies $2.1M (3.6%) Traditional & Herbal $1.4M (2.4%) Vaccines $0.11M (0.2%) Medicine Ingredients $0.10M (0.2%)
Top Products — FY 2025–26 DGCIS
Indian Pharma Investment in Mauritius Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Mauritius: $504M across 101 filings (2011-2025).